Back to Results
First PageMeta Content
Clinical research / Pharmaceuticals policy / Pharmacy / Health Products and Food Branch / Active ingredient / Drug discovery / Biologic / Ingredient / Therapeutic Products Directorate / Pharmaceutical sciences / Pharmacology / Health Canada


Policy: Interpretation of "Identical Medicinal Ingredients"
Add to Reading List

Document Date: 2013-07-12 14:25:51

Open Document

File Size: 22,62 KB

Share Result on Facebook

City

Ottawa / /

Country

Canada / /

/

Facility

Pharmaceutical Sciences Therapeutic Products Directorate Health Canada Finance Building / /

/

IndustryTerm

health products / pharmaceutical equivalence / chemical bonding interactions / hydration products / chemical entity / chemical identicality / drug product / subsequent market-entry product / chemical structure / drug products / reference product / equivalent drug products / food / /

MedicalCondition

disease / /

Organization

Health Products and Food Branch / Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada Finance Building / Therapeutic Products Directorate / Biologics and Genetic Therapies Directorate / /

/

Position

Minister of Health / coordinator / /

ProvinceOrState

Ontario / /

Technology

crystallization / API / /

URL

http /

SocialTag